BENITO CANO: Open Payments
NPI 1487093308 · BROWNSVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$905 in 36 payments from 6 companies in 2025. Trend: 2023 $1,548 · 2024 $1,153 · 2025 $905
Food & beverage: $905
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $388 |
| Lilly USA, LLC | 16 | $291 |
| Exelixis Inc. | 1 | $123 |
| GlaxoSmithKline, LLC. | 3 | $69 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
Products named: VRAYLAR, ZEPBOUND, CABOMETYX, MOUNJARO, TRELEGY ELLIPTA, JARDIANCE, FARXIGA, Rybelsus.
Industry payments across TX — which companies pay providers there.
